Related Experiment Video
Updated: May 5, 2026

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Published on: February 15, 2019
COVID-19 Organ Injury Pathology and D-Dimer Expression Patterns: A Retrospective Analysis
Raluca Dumache1,2, Camelia Oana Muresan1,2, Sorina Maria Denisa Laitin3
1Department of Forensic Medicine, Bioethics, Medical Ethics and Medical Law, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Insights
Elevated D-dimer levels in COVID-19 patients correlate with increased multi-organ damage, particularly in the lungs and heart. This highlights hypercoagulability
Area of Science:
- Pathology
- Hematology
- Infectious Diseases
Background:
- Coronavirus Disease 2019 (COVID-19) can lead to widespread organ damage.
- Hypercoagulability, indicated by elevated D-dimer, is a known COVID-19 complication.
- The relationship between D-dimer levels and specific organ pathology in COVID-19 requires further elucidation.
Purpose of the Study:
- To evaluate pathological changes in COVID-19 patients.
- To analyze organ-specific lesions in relation to D-dimer levels.
- To investigate the prognostic significance of D-dimer in COVID-19 outcomes.
Main Methods:
- Retrospective review of 69 COVID-19 autopsied or deceased patients.
- Cataloging of pathological findings: pulmonary microthrombi, bronchopneumonia, myocardial fibrosis, hepatic steatosis, renal tubular necrosis.
- Subgroup analysis based on D-dimer categories (<500, 500-2000, ≥2000 ng/mL) and correlation with clinical/laboratory data.
Main Results:
- Marked organ pathology was significantly more frequent in the highest D-dimer group (≥2000 ng/mL).
- Pulmonary, myocardial, and renal lesions showed increased prevalence with higher D-dimer levels.
- Severe lung and heart pathologies correlated with high inflammatory markers and increased risk of ICU admission and mortality.
Conclusions:
- COVID-19-related organ damage is amplified in patients with significantly elevated D-dimer.
- Hypercoagulability and systemic inflammation play a crucial role in multi-organ complications.
- D-dimer stratification can guide tailored management for high-risk COVID-19 patients.
Abstract:
Background and Objectives: Coronavirus Disease 2019 (COVID-19) may cause extensive multi-organ pathology, particularly in the lungs, heart, kidneys, and liver. While hypercoagulability-often signaled by elevated D-dimer-has been thoroughly investigated, the concurrent pathological findings across organs and their interrelation with distinct D-dimer levels remain incompletely characterized. This study aimed to evaluate the pathological changes observed in autopsied or deceased COVID-19 patients, focusing on the prevalence of organ-specific lesions, and to perform subgroup analyses based on three D-dimer categories. Methods: We conducted a retrospective review of 69 COVID-19 patients from a Romanian-language dataset, translating all clinical and pathological descriptions into English. Pathological findings (pulmonary microthrombi, bronchopneumonia, myocardial fibrosis, hepatic steatosis, and renal tubular necrosis) were cataloged. Patients were grouped into three categories by admission D-dimer: <500 ng/mL, 500-2000 ng/mL, and ≥2000 ng/mL. Laboratory parameters (C-reactive protein, fibrinogen, and erythrocyte sedimentation rate) and clinical outcomes (intensive care unit [ICU] admission, mechanical ventilation, and mortality) were also recorded. Intergroup comparisons were performed with chi-square tests for categorical data and one-way ANOVA or the Kruskal-Wallis test for continuous data. Results: Marked organ pathology was significantly more frequent in the highest D-dimer group (≥2000 ng/mL). Pulmonary microthrombi and bronchopneumonia increased stepwise across ascending D-dimer strata (p < 0.05). Myocardial and renal lesions similarly showed higher prevalence in patients with elevated D-dimer. Correlation analysis revealed that severe lung and heart pathologies were strongly associated with high inflammatory markers and a greater risk of ICU admission and mortality. Conclusions: Our findings underscore that COVID-19-related organ damage is magnified in patients with significantly elevated D-dimer. By integrating pathology reports with clinical and laboratory data, we highlight the prognostic role of hypercoagulability and systemic inflammation in the pathogenesis of multi-organ complications. Stratifying patients by D-dimer may inform more tailored management strategies, particularly in those at highest risk of severe pathology and adverse clinical outcomes.
More Related Videos
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention

